Cell cycle and cancer: Critical events at the G1 restriction point

Critical Reviews in Oncogenesis

Volumn 7, Issue 1-2, 1996, Pages 127-142

  DelSal, Giannino ^a   Loda, Massimo ^b   Pagano, Michele ^c  

^a Laboratorio Nazionale CIB   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

cancer; cell cycle; Cki; cyclin; cyclin dependent kinase; tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE;

CANCER; CELL CYCLE; HUMAN; NONHUMAN; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030434824     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v7.i1-2.80     Document Type: Review

References (156)

1. Almendral, J. M., D. Sommer, H. Macdinald-Bravo, J. Burckhardt, and J. B. R. Perera: Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol. Cell. Biol., 8:2140-2148 (1988).
2. Ataiada, P., H. Wong, C. Veilette, and K. Riabowol: Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp. Cell Res., 217:205-216 (1995).
3. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev., 7:812-821 (1993).
4. Bartkova, J., J. Lukas, H. Muller, D. Lutzhoft, M. Strauss, and J. Bartek: Cyclin D1 protein expression and function in human breast cancers. Int. J. Cancer, 57:353-361 (1994).
5. Bates, S., L. Bonetta, D. MacAllan, D. Parry, A. Holder, C. Dickson, and G. Peters: Cdk6 (PLSTIRE) and Cdk4 (PSK-J3) are distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene, 9:71-79 (1994a).
6. Bates, S., D. Parry, L. Bonetta, K. Vousden, C. Dickson, and G. Peters: Absence of cyclin D/Cdk complexes in cells lacking functional retinoblastoma protein. Oncogene, 9:1633-1640 (1994b).
7. Berenson, J., H. Koga, J. Yang, J. Pearl, E. Holmes, R. Figlin, and T. L. C. S. Group: Frequent amplification of the BCL-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncogene, 5:1343-1348 (1990).
8. Bodrug, S., B. Warner, M. Bath, G. Lindeman, A. Harris, and J. Adams: Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J., 13:2124-2130 (1994).
9. Brancolini, C., M. Benedetti, and C. Schneider: Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE like proteases. EMBO J., 14:5179-5190 (1995).
10. Buckley, M. F., K. J. E. Sweeney, J. A. Hamilton, R. L. Sini, D. L. Manning, R. I. Nicholson, A. deFazio, C. K. W. Watts, A., M. E., and R. L. Sutherland: Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8:2127-2133 (1993).
11. Cavanaugh, A. H., W. M. Hempel, L. J. Taylor, V. Rogalsky, G. Todorov, and L. I. Rothblum: Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature, 374:177-180 (1995).
12. ink4 Mol. Cell. Biol., 15:2682-2688 (1995).
13. Chen, C., Y. Chen, K. Dai, P. Chen, D. Riley, and W. H. Lee: A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol. Cell. Biol., 16:4691-4699 (1996).
14. Coleman, T. and W. Dunphy: Cdc2 regulatory factors. Curr. Opin. Cell. Biol., 6:877-882 (1994).
15. Coppock, D. L. and C. Kopman: Regulation of gene expression in human diploid fibroblasts (WI38). J. Cell. Biol., 115:275-282 (1991).
16. D'Urso, G., R. Marraccino, D. Marshak, and J. Roberts: Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science, 250:786-791 (1990).
17. DeCaprio, J., Y. Furukawa, F. Ajchenbaum, J. D. Griffin, and D. M. Livingston: The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl Acad. Sci. U.S.A., 89:1795-1798 (1992).
18. DeCaprio, J. A., J. W. Ludlow, J. Figge, J. Y. Shew, C. M. Huang, W. H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston: SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54:275-283 (1988).
19. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, W. H. Piwnica,C. M. Huang, and D. M. Livingston: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell, 58:1085-1095 (1989).
20. Defeo, D., P. Huang, R. Jones, K. Haskell, G. Vuocolo, M. Hanobik, H. Huber, and A. Oliff: Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature, 351:251-254 (1991).
21. DeGregori, J., T. Kowalik, and J. R. Nevins: Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol., 15:4215-4224 (1995).
22. Del Sal, G., M. Murphy, E. Ruaro, D. Lazarevic, A. J. Levine, and C. Schneider: Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene, 12:177-185 (1996).
23. Del Sal, G., E. Ruaro, R. Utrera, A. Levine, C. Cole, and C. Scheider: Gas1-induced growth suppression requires a transactivation-independent p53 function. Mol. Cell. Biol., 15:7152-7160 (1995).
24. DelSal, G., M. E. Ruaro, L. Philipson, and C. Schneider: The growth arrest-specific gene, gas1, is involved in growth suppression. Cell, 70:595-607 (1992).
25. Dirick, L., T. Bohm, and K. Nasmith: Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae. EMBO J., 14:4803-4813 (1995).
26. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg: Physical interaction of the retinoblastima protein with human D cyclins. Cell, 73:499-511 (1993).
27. Dulic, V., L. Drullinger, E. Lees, S. Reed, and G. Stein: Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc. Natl. Acad. Sci. U.S.A., 90:11034-11038 (1993).
28. Dulic, V., W. Kaufmann, S. Wilson, T. Tlsty, E. Lees, W. Harper, S. Elledge, and S. Reed: p53-dependent inhibi- tion of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76:1013-1023 (1994).
29. Dulic, V., E. Lees, and S. I. Reed: Association of human cyclin E with a periodic G1-S phase protein kinase. Science, 257:1958-1961 (1992).
30. Dutta, A., R. Chandra, L. Leiter, and S. Lester: Cyclins as markers of tumor proliferation: immmunocytochemical studies in breast cancer. Proc. Natl. Acad. Sci. U.S.A., 92:5386-5390 (1995).
31. Dyson, N., P. M. Howley, K. Münger, and E. Harlow: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 242:934-937 (1989).
32. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 55:2910-2919 (1995).
33. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein: WAF1, a potential mediator of p53 tumor suppression. Cell, 75:817-825 (1993).
34. Esposito, V., A. Baldi, A. DeLuca, G. Sgaramella, G. G. Giordano, M. Caputi, F. Baldi, M. Pagano, and A. Giordano: Prognostic role of the cell cycle inhibitor p27 in non-small cell lung cancer. Submitted (1997).
35. Evan, G., L. Brown, L. Brown, M., W., and E. Harrington: Apoptosis and cell cycle. Curr. Opin. Cell. Biol., 7:825-834 (1995).
36. Ewen, M.: The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev., 13:45-66 (1994).
37. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Y. Kato, and D. M. Livingston: Functional interaction of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73:487-497 (1993).
38. Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson: Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9:2364-2372 (1995).
39. Kip1-deficient mice. Cell, 85:733-744 (1996).
40. Fornace, A. J., Jr.: Mammalian genes induced by radiation. Annu. Rev. Genet., 26:507-526 (1992).
41. Fornace, A. J. J., D. W. Nebert, M. C. Hollander, J. D. Luethy, and M. Papathanasiou: Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol., 9:4196-4203 (1989).
42. Galaktionov, K., X. Chen, and D. Beach: Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382:511-517 (1996).
43. Galaktionov, K., A. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach: Gdc25 phqsphatases as potential human oncogenes. Science, 269:1575-1577 (1995).
44. Geng, Y., E. Ng Eaton, M. Picon, J. Roberts, A. Lundberg, A. Gifford, C. Sardet, and R. Weinberg: Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene, 12:1173-1180 (1996).
45. Giordano, A., P. Whyte, E. Harlow, B. R. Franza, D. Beach, and G. Draetta: A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell, 58:981-990 (1989).
46. Girard, F., U. Strausfeld, A. Fernandez, and N. Lamb: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell, 67:1169-1179 (1991).
47. Gorski, D. H., D. F. LePage, C. V. Patel, N. G. Copeland, N. A. Jenkins, and K., W.: Molecular cloning of a diverged homeobox gene that is rapidly down regulated during the G0/G1 transition in vascular smooth muscle cells. Mol. Cell. Biol., 13:3722-3733 (1993).
48. Greenblatt, M., W. Bennett, M. Hollstein, and C. Harris: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54:4855-4878 (1994).
49. Gu, Y., C. Turck, and D. Morgan: Inhibition of Cdk2 activity in vivo by an associated 20K regulatory subunit. Nature, 366:707-710 (1993).
50. Guan, K., C. Jenkins, Y. Li, M. Zariwala, S. Noh, X. Wu, and Y. Xiong: Molecular cloning of the CDK6 inhibitor p20 and demonstration of the opposite effects of cyclin on the two CDK inhibitor families' binding to CDKs. Mol. Cell. Biol., 7:57-70 (1996).
51. Guan, K., C. Jenkins, M. Nichols, X. Wu, C. O'Keefe, G. Matera, and Y. Xiong: Growth suppression by p18, a p16Ink4/Mts1- and Mts2-related Cdk6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8:2939-2952 (1994).
52. Hannon, G. J. and D. Beach: p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371:257-261 (1994).
53. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75:805-816 (1993).
54. Hartwell, L. H.: Twenty-five years of cell cycle genetics. Genetics, 129:975-980 (1991).
55. Hartwell, L. H., J. Cullotti, and B. Reid: Genetic control of cell division in yeast I detection of mutants. Proc. Natl. Acad. Sci. U.S.A., 66:352-359 (1970).
56. Hartwell, L. H. and M. B. Kastan: Gell cycle control and cancer. Science, 266:1821-1828 (1994).
57. Herrera, R. E., V. P. Sah, B. O. Williams, T. P. Makela, R. Weinberg, and T. Jacks: Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in RB-deficient fibroblasts. Mol. Cell. Biol., 16:2402-2407 (1996).
58. Hinds, P., S. Dowdy, E. Ng-Eaton, A. Arnold, and R. Weinberg: Function of a human cyclin as an oncogene. Proc. Natl. Acad. Sci. U.S.A., 91:709-713 (1994).
59. Hirai, H., M. Roussel, J. Kato, R. Ashmun, and C. Sherr: Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15:2672-2681 (1995).
60. Hirai, H. and H. Sherr: Interaction of D type cyclins with a novel Myb-like factor, DMP1. Mol. Cell. Biol., 16:6457-6467 (1996).
61. Hunter, T. and J. Pines: Cyclins and cancer II: cyclin D and Cdk inhibitors come of age. Cell, 79:573-582 (1994).
62. Hussussian, C. J., J. P. Struewing, A. M. Goldstein, P. Higgins, D. S. Ally, M. D. Sheahan, J. Clark, W. H., M. A. Tucker, and N. C. Dracopoli: Germline p 16 mutations in familial melanoma. Nature Genet., 8:15-18 (1994).
63. Jen, J., W. Harper, S. Bigner, D. Bigner, N. Papadopoulos, S. Markowitz, J. Willson, K. Kinder, and B. Vogelstein: Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54:6353-6358 (1994).
64. Jiang, W., S. Kahan, N. Tomita, Y. Zhang, S. Lu, and B. Weinstein: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52:2980-2983 (1992).
65. Jiang, W., S. M. Kahn, P. Zhou, Y. Zhang, A. M. Cacace, A. S. Infante, S. Doi, R. M. Santella, and I. B. Weinstein: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8:3447-3457 (1993).
66. Kaelin, W., W. Krek, W. Sellers, J. DeCaprio, F. Ajchenbaum, C. Fuchs, T. Chittenden, Y. F. Li, P., M. Blanar, D. Livingston, and E. Remington: Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E27-like properties. Cell, 70:351-364 (1992).
67. Kamb, A., D. Shattuck-Eidens, R. Eeles, Q. Liu, N. A. Gruis, W. Ding, C. Hussey, T. Tran, Y. Miki, J. Weaver-Feldhaus, M. McClure, J. F. Aitken, D. E. Anderson, W. Bergman, R. Frants, D. E. Goldgar, A. Green, R. MacLennan, N. G. Martin, L. J. Meyer, P. Youl, J. J. Zone, M. H. Skolnick, and L. A. Cannon-Albright: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet., 8:22-26 (1994).
68. Kastan, M., Q. Zhan, W. El-Deiry, F. Carrier, T. Jacks, W. Walsh, B. Plunkett, B. Volgelstein, and A. Fornace: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell, 71:587-597 (1992).
69. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr: Direct binding of cyclin D to the retinoblastoma product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7:331-342 (1993).
70. Kawamat, A. N., R. Morosetti, C. Miller, D. Park, K. Spirin, T. Nakamaki, S. Takeuchi, Y. Hatta, J. Simpson, S. Wilczynski, Y. Lee, C. Bartram, and H. Koeffler, H.: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/kip1 in human malignancies. Cancer Res., 55:2266-2269 (1995).
71. Keyomarsi, K. and A. Pardee: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl Acad. Sci. U.S.A., 90:1112-1116 (1993).
72. Keyomarsi, K. and A. Pardee: Cyclin E - a better prognostic marker for breast cancer than cyclin D? Nature Med., 2:254 (1996).
73. Kiyokawa, H., R. Kineman, K. Manova-Todorova, V. Soares, E. Hoffman, M. Onoi, A. Hayday, D. Frohman, and Koff, A.: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell, 85:721-732 (1996).
74. Koch, C., A. Schleiffere, G. Ammer, and K. Nasmith: Switching transcription on and off during the yeast cell cycle: Cln/Cdc28 kinases activate bound transcription factor SBF (Swi4/SW6) at START, whereas Clb/Cdc28 kinases displace it from the promoter in G2. Genes Dev., 10:129-141 (1996).
75. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. M. Roberts: Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell, 66:1217-1228 (1991).
76. Koff, A., A. Giordano, D. Desai, K. Yamashita, W. Harper, S. Elledge, T. Nishimoto, D. Morgan, R. Franza, and J. Roberts: Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell-cycle. Science, 257:1689-1693 (1992).
77. Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow: Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375:506-510 (1995).
78. La Thangue, N.: DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. TIBS, 19:108-114 (1994).
79. Lammie, G., V. Fantl, R. Smith, E. Schuuring, S. Brookes, R. Michalides, C. Dickson, A. Arnold, and G. Peters: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinimas and linked to BCL-1. Oncogene, 6:439-444 (1991).
80. KIP2 cyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9:639-649 (1995).
81. Lew, D. J., V. Dulic, and S. I. Reed: Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast. Cell, 66:1197-1206 (1991).
82. Loda, M., B. Cukor, S. Tam, P. Lavin, M. Fiorentino, G. Draetta, J. Jessup, and M. Pagano: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med., In press (1997).
83. Lovec, H., A. Sewing, F. Lucibello, R. Mueller, and T. Moroy: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9:323-326 (1994).
84. Lukas, J., J. Bartkova, M. Rodhe, M. Strauss, and J. Bartek: Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol., 15:2600-2611 (1995a).
85. Lukas, J., H. Müller, J. Bartkova, D. Spitkovsky, A. Kjerulff, P. Jansen-Durr, M. Strauss, and J. Bartek: DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol., 125:625-638 (1994a).
86. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene, 9:707-718 (1994b).
87. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek: Retinoblastoma- protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature, 375:503-506 (1995b).
88. Mal, A., R. Poon, P. Howe, H. Toyoshima, T. Hunter, and M. Harter: Inactivation of p27kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature, 380:262-265 (1996).
89. Marcu, K. B., S. A. Bossone, and A. Patel: myc function and regulation. Annu. Rev. Biochem., 61:809-860 (1992).
90. CIP1 Cdk inhibitor family is a candidate tumor suppressor gene. Genes Dev., 9:650-662 (1995).
91. Matsushime, H., M. Roussel, R. Ashmun, and C. J. Sherr: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell, 65:701-713 (1991a).
92. 1. Cold Spring Harbor Symp. Quant. Biol., 56:(1991b).
93. Medema, R. H., R. E. Herrera, F. Lam, and R. A. Weinberg: Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. U.S.A., 92:6289-6293 (1995).
94. Meyerson, M. and E. Harlow: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14:2077-2086 (1994).
95. Motokura, T. and A. Arnold: Cyclin D and oncogenesis. Curr. Opin. Genet. Dev., 3:5-10 (1993).
96. Motokura, T., T. Bloom, Y. G. Kim, H. Jueppner, J. Ruderman, H. Kronenberg, and A. Arnold: A novel cyclin encoded by a bell-linked candidate oncogene. Nature, 350:512-515 (1991).
97. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, N., I., H., D. Loh, and K. Nakayama: Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85:707-720 (1996).
98. Noda, A., Y. Ning, S. Venable, O. Pereira-Smith, and J. R. Smith: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res., 211:90-98 (1994).
99. Norbury, C. and P. Nurse: Animal cell cycles and their control. Annu. Rev. Biochem., 61:441-470 (1992).
100. Ohtsubo, M. and J. Roberts: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science, 259:1908-1912 (1993).
101. Ohtsubo, M., A. M. Theodoras, J. Schumacher, M., R. J., and M. Pagano: Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol. Cell. Biol., 15:2612-2124 (1995).
102. Oppenheim, R., W.: Cell death during development of the nervous system. Annu Rev. Neurosci., 14:435-501 (1991).
103. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta: Cyclin A is required at two points in the human cell cycle. EMBO J., 11:761-771 (1992).
104. Pagano, M., S. W. Tam, A. M. Theodoras, P. Romero-Beer, G. Del Sal, V. Chau, R. Yew, G. Draetta, and M. Rolfe: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269:682-685 (1995).
105. Pagano, M., A. M. Theodoras, S. W. Tam, and G. Draetta: Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev., 8:1627-1639 (1994).
106. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55:1206-1210 (1995).
107. Pines, J. and T. Hunter: Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature, 346:760-763 (1990).
108. kip1 a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 79:59-66 (1994).
109. Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55:1211-1214 (1995).
110. Proctor, A., L. Coombs, J. Cairns, and M. A. Knowles: Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene, 6:789-795 (1991).
111. INK4b genes. Oncogene, 11:635-645 (1995).
112. Quelle, D., R. Ashmun, S. Shurtleff, J. Kato, D. Bar-Sagi, M. Roussel, and C. Sherr: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev., 7:1559-1571 (1993).
113. Resnitzky, D., M. Gossen, H. Bujard, and S. Reed: Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol. Cell. Biol., 14:1669-1679 (1994).
114. Richardson, H., L. O'Keefe, S. Reed, and R. Saint: A drosophila G1-specific cyclin E homolog exhibits different modes of expression during embryogenesis. Development, 119:673-690 (1993).
115. Riley, D. J., E. Y.-H. P. Lee, and W.-H. Lee: The retinoblastoma protein: more that a tumor suppressor. Annu. Rev. Cell. Biol. (1994).
116. Rosenberg, C. L., T. Motokura, H. M. Kronenberg, and A. Arnold: Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Oncogene, 8:519-521 (1993).
117. Roussel, M., A. M. Theodoras, M. Pagano, and C. J. Sherr: Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. U.S.A., 92:6837-6841 (1995).
118. Schneider, B., Q. Ying, and B. Futcher: Linkage of replication to start by the cdk inhibitor sic1. Science, 272:560-562 (1996).
119. Schneider, C., R. King, and L. Phiplipson: Genes specifically expressed at growth arrest of mammalian cells. Cell, 54:787-793 (1988).
120. Schuuring, E., E. Verhoeven, H. van Tinteren, J. Peterse, B. Nunnink, F. Thunnissen, P. Devilee, C. Cornelisse, M. van de Vijver, W. Mooi, and R. Michalides: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52:5229-5234 (1992).
121. Schwob, E., T. Böhm, M. Mendenhall, and K. Nasmyth: The B-type cyclin kinase inhibitor p40sic1 controls the G1 to S transition in S. cerevisiœ. Cell, 79:233-244 (1994).
122. Schwob, E. and K. Nasmyth: CLB5 and CLB6, a new pair of B type cyclins involved in DNA replication in Saccharomyces cerevisiae. Genes Dev., 7:1160-1175 (1993).
123. INK4 Science, 267:249-252 (1995).
124. Serrano, M., G. J. Hannon, and D. Beach: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/Cdk4. Nature, 366:704-707 (1993).
125. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R. DePinho: Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85:27-37 (1996).
126. Seto, M., K. Yamamoto, S. Iida, Y. Akao, K. R. Utsumi, I. Kubonishi, I. Miyoshi, T. Ohtsuki, Y. Yawata, M. Namba, T. Motokura, A. Arnold, T. Takahashi, and R. Ueda: Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14) (q13;q32)translocation. Oncogene, 7:1401-1406 (1992).
127. Sewing, A., V. Ronicke, C. Burger, M. Funk, and R. Muller: Alternative splicing of human cyclin E. J. Cell Sci., 107:581-588 (1994).
128. Sheaff, R. J. and J. M. Roberts: Lesson in p16 from phylum falconium. Curr. Biol., 5:28-31 (1995).
129. Sherr, C.: Cancer cell cycles. Science, 274:1672-1677 (1996).
130. Sherr, C. and J. Roberts: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9:1149-1163 (1995).
131. Sherr, C. J.: The ins and outs of Rb: coupling gene expression to the cell cycle clock. Trends Cell Biol., 4:15-18 (1994).
132. Sicinski, P., J. Donaher, S. Parker, T. Li, A. Fazeli, H. Gardner, S. Haslam, R. Bronson, S. Elledge, and R. Weinberg: Cyclin D1 provides a link between development and oncogenesis in the retina nad breast. Cell, 82:621-630 (1995).
133. Stegmaier, K., S. Takeuchi, T. Golub, S. Bhohlander, C. Bartram, P. Koeffler, and G. Gilliland: Mutational analysis of the candidate tumor suppressor genes Tel and Kip1 in childhood acute lymphoblastic leukemia. Cancer Res., 56:1413-1417 (1996).
134. Ink4 Cancer Res., 54:5816-5820 (1994a).
135. Tam, S. W., A. M. Theodoras, J. W. Shay, G. F. Draetta, and M. Pagano: Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene, 9:2663-2674 (1994b).
136. Tan, P., B. Cady, M. Wanner, P. Worland, B. Cukor, M. Fiorentino, C. Magi-Galluzzi, P. Lavin, M. Pagano, and M. Loda: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Submitted (1997).
137. Toyoshima, and T. Hunter: p27, a novel inhibitor of G1-cyclin-cdk protein kinase activity, is related to p21. Cell, 78:67-74 (1994).
138. Tyers, M., G. Tokiwa, and B. Futcher: Comparison of the S. cerevisiae G1 cyclins: Cln3 may be an upstream activator of Cln1, Cln 2. EMBO J., 12:1955-1968 (1993).
139. Wang, J., X. Chenivesse, B. Henglein, and C. Brechot: Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature, 343:555-557 (1990).
140. Wang, J. and K. Walsh: Resistence to apoptosis conferred by Cdk inhibitors myocyte differentiation. Science, 273:(1996).
141. Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature, 369:669-671 (1994).
142. Weinberg, R. A.: The retinoblastoma gene and cell control. Cell, 81:323-330 (1995).
143. Weinstat-Saslow, D., M. Merino, R. Manrow, J. Lawrence, R. Bluth, K. Wittenbel, J. Simpson, D. Page, and P. Steeg: Overexpression of cyclin D1 mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med., 1:1257-1260 (1995).
144. Whyte, P., K. Buchkovich, J. Horowitz, S. Friend, M. Raybuck, R. Weinberg, and E. Harlow: Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature, 334:124-129 (1988).
145. Withers, D., R. Harvey, J. Faust, O. Melnyk, K. Carey, and T. Meeker: Characterization of a candidate bcl-1 gene. Mol. Cell. Biol., 11:4846-4853 (1991).
146. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science, 269:1281-1284 (1995).
147. Xiong, Y., T. Connolly, B. Futcher, and D. Beach, D.: Human D-type cyclin. Cell, 65:691-699 (1991).
148. Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach: p21 is a universal inhibitor of the cyclin kinases. Nature, 366:701-704 (1993a).
149. Xiong, Y., H. Zhang, and D. Beach: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71:504-514 (1992).
150. Xiong, Y., H. Zhang, and D. Beach: Subunit rearrangement of the cyclin dependent kinases is associated with cellular transformation. Genes Dev., 7:1572-1583 (1993b).
151. Kip1 by the human papillomavirus 16 E7 oncoprotein. Oncogene, 13:In press (1996).
152. Zetterberg, A. and O. Larson: Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. U.S.A., 82:5365-5369 (1985).
153. Zetterberg, A., O. Larsson, and K. G. Wiman: What is the restriction point? Curr. Opin. Cell Biol., 7:835-842 (1995).
154. Zhan, Q., K. A. Lord, I. Alamo, F. Hollander, F. Carrier, D. Ron, K. W. Kohn, B. Hoffman, D. A. Lieberman, and A. J. Fornace: The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell. Biol., 14:2361-2371 (1994).
155. Zhang, H., Y. Xiong, and D. Beach: PCNA and p21 are universal elements of the cell cycle kinase family. Mol. Cell. Biol., 4:897-906 (1993).
156. Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, J. Wang, D. Fesquet, B. Henglein, and C. Brechot: Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun., 182:1144-1154 (1992).